-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1596

Benzinga·10/30/2026 18:03:03
Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1430 to $1596.